Valid Results, Inc.
Already registered?
Sign in here!
Abnormal Uterine Bleeding /
Global Endometrial Ablation Reports
Oral Birth Control/Hormone Therapy Reports
Methodology of the Following Reports
The sample design specified a minimum of 100 qualified US participants to be selected randomly from a database of AMA certified Ob/Gyn’s. A random sample of N=100 yields parameter estimates at 95% confidence +/- 10% bound on the error of estimation. Upon completion of the SAQ, 20 of the participants were selected to participate in a follow-up depth interview conducted via the telephone.
Trends in Procedures for the Treatment of AUB
This report details the number of various minimally invasive and open procedures performed by Ob/Gyn surgeons for the treatment of AUB, as well as the share of each procedure by site of care (i.e. hospital, surgery center, office, etc.). Also included is a detailed segmentation analysis comparing minimally invasive AUB specialists, open AUB specialists, general AUB specialists and surgeons performing a low volume of AUB procedures.
Patient Characteristics and Treatment Modalities for AUB
The report provides insight into the frequencies of conditions causing AUB, the percentage of patients electing various treatments (i.e. no treatment, Rx therapy, minimally invasive procedure, etc.) and demographic information on the patients (age, race, etc.). The reader will discover the size of a patient segment that is untapped due to needs not being met by currently available treatment alternatives.
Applying the 80/20 Rule to AUB Specialists
This report segments the segment of Ob/Gyn surgeons that perform the majority of the AUB procedures. The segment is then examined relative to other segments of Ob/Gyn surgeons to uncover the characteristics of these AUB "specialists."
An Evaluation of Sales Reps Among Global Endometrial Ablation Competitors.
This report compares Ob/Gyn surgeons experience with and perceptions of sales reps from featured GEA companies. Includes a comparison of reps from American Medical Systems (Her Option), Boston Scientific (Hydrothermablator), Cytyc/Hologic (NovaSure), Ethicon Women’s Health (THERMACHOICE), and Microsulis (MEA Microwave Endometrial Ablation). The information provides an objective means to evaluate sales reps within the same product category, and detailed analysis provides insight into the characteristics of surgeons that each companies are targeting in their sales strategies.
An Evaluation of Professional Education Programs Among Global Endometrial Ablation Competitors
This report provides a comparison of Ob/Gyn surgeons' experience with and perceptions of professional education sponsored by featured GEA manufacturers . Also included is a comparison of events from American Medical Systems (Her Option), Boston Scientific (Hydrothermablator), Cytyc/Hologic (NovaSure), Ethicon Women’s Health (THERMACHOICE), and Microsulis (MEA Microwave Endometrial Ablation). The information provides an objective means to evaluate professional education within the same product category, and detailed analysis provides insight into the characteristics of surgeons that are attending both your company's and your competitors' professional education events.
How do Ob/Gyn Surgeons Who Perform Global Endometrial Ablation Procedures Prefer to be Trained and Educated on New Products, Procedures and Methods?
Determines Ob/Gyn surgeons' preferences for learning about new products and techniques as well as preferred methods of training. Includes a segmentation analysis integrating attitudes and procedural volume to identify unique segments of surgeons and analyzes differences in their training and educational preferences.
Considerations that Shape Product Preferences in Obstetric and Gynecology
Validate your strategies for marketing to Ob/Gyn surgeons with an understanding of the considerations that shape their product preferences. This report investigates segments within the Ob/Gyn market to provide you with insight into how key segments differ in their perceptions of importance of featured considerations.
Analysis of the Ob/Gyn Market Dynamics and Future Trends Among Leading Global Endometrial Ablation Systems
This report analyzes Ob/Gyn surgeons' use of leading Global Endometrial Ablation systems, as well as surgeons' propensity to cross-use competitors' substitute systems. Also included is an in-depth analysis of the brand switching dynamics and the future trends for use of the featured devices. Devices featured in the questionnaire are: Her Option (American Medical Systems), Hydrothermablator (Boston Scientific), NovaSure (Cytyc/Hologic), THERMACHOICE (Gynecare/Ethicon Women's Health, and the MEA Microwave Endometrial Ablation (Microsulis).
An Identification and Quantification of the Evaluation Criteria Used by Ob/Gyn Surgeons to Evaluate Global Endometrial Ablation Companies
An in-depth measurement of the various criteria Ob/Gyn surgeons' use to evaluate manufactures, as well as the level of influence each criterion has in the evaluation process. The analyses also examine the differences in the evaluation processes of various obstetrics and gynecology segments, including those who specialize in AUB patients, AUB procedures and/or GEA procedures. Provides an understanding of how company images and positioning evolve.
Assessing the Strengths of Associations Between GEA Brands and their Manufacturers
How strong is the association between your company and your GEA product? What percent of Ob/Gyn surgeons correctly match your brand to your manufacturer? Are you maximizing your product's brand strength by fully leveraging your company brand? This report compares the relative strengths of brand-manufacturer associations from a variety of perspectives, comparing companies and products as well as segments of surgeons (i.e. compares customers vs. noncustomers for featured GEA products, surgeons specializing in AUB procedures, surgeons specializing in GEA procedures, etc.) Companies included: American Medical System, Boston Scientific, Cytyc/Hologic, Ethicon Women’s Health and Microsulis.
How Competing GEA Companies are Positioned in the Minds of Ob/Gyn Surgeons
The report measures Ob/Gyn surgeons' perceptions of featured GEA manufacturers' performance in a variety of areas, and examines demographical differences between the typical customers for each featured brand. Products/companies included are: Her Option (American Medical Systems), Hydrothermablator (Boston Scientific), NovaSure (Cytyc/Hologic), THERMACHOICE (Gynecare/Ethicon Women’s Health, and the MEA Microwave Endometrial Ablation (Microsulis).
Importance, Performance and Relative Position; A Gap Analysis that Identifies Opportunities for GEA Manufacturers
The report identifies unmet needs in the obstetrics and gynecology, both in the GEA market overall and for specific GEA manufacturers. It also assesses the fit of each product with its customers, and quantifies the percentage of a each product's customers that may be at risk. Risk is determined by segmenting GEA customers who use a given product but whose needs will better met by a competitive product. Opportunities are supported by providing an understanding of surgeons perceptions of the importance of product considerations and the relative performance of featured products. Featured companies include: American Medical System, Boston Scientific, Cytyc/Hologic, Ethicon Women’s Health, and Microsulis.
